Geno J Germano bought $30k of ENTX
director at Entera Bio Ltd.. 20,000 shares at an average of $1.49, traded Feb 10, 2026, filed Feb 11, 2026.
Score components
- +15RoleDirector
- +5Trade size$30k at market
- 0Relative to holdingsHoldings before the trade unknown
- +8Price context54% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -22.6%, 3m -21.3%, 6m +70.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001178913-26-000413, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | POpen-market purchase Ordinary Shares, par value NIS 0.0000769 per share | +20,000 | $1.49 | $30k | - | Feb 11, 2026 |
Related signals
Other insiders at Entera Bio Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Entera Bio Ltd. | Geno J Germano director | $26k 20,000 shares | +100% | |
| 39Weak | Entera Bio Ltd. | Sean Ellis director | $12k 10,000 shares | +6% | |
| 53Moderate | Entera Bio Ltd. | Steven D Rubin director | $7,450 5,000 shares | +50% | |
| 41Moderate | Entera Bio Ltd. | Sean Ellis director | $22k 18,000 shares | +11% | |
| 46Moderate | Entera Bio Ltd. | Steven D Rubin director | $12k 10,000 shares | - | |
| 38Weak | Entera Bio Ltd. | Haya Taitel director | $11k 7,500 shares | - | |
| 25Weak | ENTXbuy Entera Bio Ltd. | Miranda Jayne Toledano Chief Executive Officer | $20k 11,000 shares | +3% | |
| 30Weak | ENTXbuy Entera Bio Ltd. | Haya Taitel director | $9,405 9,500 shares | +37% | |
| 29Weak | ENTXbuy Entera Bio Ltd. | Haya Taitel director | $5,864 7,615 shares | +42% | |
| 47Moderate | Entera Bio Ltd. | Miranda Jayne Toledano Chief Executive Officer | $17k 23,952 shares | +28% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.